ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Brief Intervention to Reduce STDs in ER Drug Users - 1

This study is currently recruiting participants.
Verified by National Institute on Drug Abuse (NIDA), September 2005

Sponsors and Collaborators: National Institute on Drug Abuse (NIDA)
Boston Medical Center
Information provided by: National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier: NCT00218400
  Purpose

The purpose of this study is to test whether a brief motivational interview focused on sexual practices will facilitate behavior change, risk reduction and reduced rate of sexually transmitted infections among emergency department patients who use heroin and cocaine and are out-of-treatment for their substance abuse.


Condition Intervention Phase
Substance-Related Disorders
Sexual Risk Behaviors
Behavioral: Motivational interviewing
Phase II

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Prevention, Randomized, Double-Blind, Active Control, Single Group Assignment, Efficacy Study
Official Title:   Brief Intervention to Reduce STDs in ER Drug Users

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • High risk sexual behaviors

Estimated Enrollment:   3340
Study Start Date:   December 2004

Detailed Description:

Project SAFE is a multidisciplinary effort to test whether brief motivational interviewing in an emergency department setting may encourage change in sex behaviors and thus prevent gonorrhea, chlamydia, and HIV among male and female patients aged 18-44 years who use heroin and/or crack/cocaine and are not in treatment. We will enroll and 1:1 randomize 3,340 patients to intervention (safe sex BNI) or control (standard counseling) over a 2.5-year period, with 6-month and 12-month follow-up. Outcome measures include: 1) comparing cumulative STD incidence and frequency of safe sex behavior between intervention and standard counseling (control) groups over a one year follow-up period; 2) STD and HIV as diagnosed by specific laboratory assay at baseline, 6-month, and 12-month follow-up; participant self-report of sexual and drug using behavior at baseline and 6 and 12 month follow-up. Sexual behavior risk will be measured in terms of proportion of vaginal and anal sex acts protected by condom use and condom use at last sexual act, by sexual partner type. Differences in cumulative incidence between intervention and control groups will be evaluated using Poisson regression with random effects modeling if needed. Differences in safe sex behavior between intervention and control groups will be evaluated using logistic regression. After assessing intervention effect in the base model, we will assess intervention effect controlling for age, gender, race, and baseline readiness to change and sexual and drug using behavior. We will conduct exploratory analyses for the potential interaction and mediating effects between intervention status and abstinence from drug use on incidence of STDs and self-reported behaviors. An effective, brief intervention for safe sex behaviors to reduce STDs and HIV among drug users in ED and UCC settings may provide a sustainable intervention opportunity for drug users who are otherwise difficult to access.

  Eligibility
Ages Eligible for Study:   18 Years to 44 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • active use of heroin and/or crack/cocaine; orientation to person, place and time; plans to remain in area; ability to provide at least one contact person for follow-up

Exclusion Criteria:

  • currently in active treatment or controlled setting
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00218400

Contacts
Contact: Anne Valentine, M.P.H.     (617)414-4556     anne.valentine@bmc.org    

Locations
United States, Massachusetts
Boston University Medical Campus     Recruiting
      Boston, Massachusetts, United States, 02118
      Contact: Ellen Jamieson, M.B.A.     617-414-5646     ellen.jamieson@bmc.org    

Sponsors and Collaborators

Investigators
Principal Investigator:     Edward Bernstein, M.D.     Boston Medical Center    
  More Information


Study ID Numbers:   NIDA-17061-1, R01-17061-1
First Received:   September 16, 2005
Last Updated:   November 3, 2005
ClinicalTrials.gov Identifier:   NCT00218400
Health Authority:   United States: Federal Government

Study placed in the following topic categories:
Mental Disorders
Substance-Related Disorders
Disorders of Environmental Origin

ClinicalTrials.gov processed this record on October 31, 2008




Links to all studies - primarily for crawlers